Men1 (menin 1) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Men1 (menin 1) Rattus norvegicus
Analyze
Symbol: Men1
Name: menin 1
RGD ID: 3078
Description: Enables chromatin binding activity. Involved in several processes, including decidualization; regulation of epithelial cell proliferation; and regulation of transcription by RNA polymerase II. Located in nucleus. Human ortholog(s) of this gene implicated in endocrine gland cancer (multiple); hyperparathyroidism; and multiple endocrine neoplasia type 1. Orthologous to human MEN1 (menin 1); PARTICIPATES IN histone modification pathway; INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 2,6-dinitrotoluene; ammonium chloride.
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: menin; MGC114329; multiple endocrine neoplasia 1; multiple endocrine neoplasia I; multiple endocrine neoplasia type I
RGD Orthologs
Human
Mouse
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81213,068,166 - 213,074,132 (+)NCBIGRCr8
mRatBN7.21203,638,905 - 203,644,871 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1203,639,000 - 203,644,871 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1211,987,807 - 211,993,657 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01219,084,356 - 219,090,206 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01211,775,412 - 211,781,262 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01221,704,394 - 221,710,343 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1221,704,493 - 221,710,331 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01228,692,520 - 228,698,433 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41209,114,987 - 209,120,837 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11209,273,349 - 209,279,258 (+)NCBI
Celera1201,172,444 - 201,178,294 (+)NCBICelera
Cytogenetic Map1q43NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
cell division  (ISO)
cell population proliferation  (ISO)
cellular response to glucose stimulus  (IEP)
cellular response to peptide hormone stimulus  (IEP)
chromatin remodeling  (ISO)
decidualization  (IEP)
DNA damage response  (IEA,ISO)
embryonic skeletal system morphogenesis  (ISO)
fibroblast apoptotic process  (ISO)
fibroblast proliferation  (ISO)
hemopoiesis  (ISO)
leukocyte homeostasis  (ISO)
MAPK cascade  (IEA,ISO)
maternal process involved in female pregnancy  (ISO)
negative regulation of cell cycle  (IBA,IEA,ISO)
negative regulation of cell cycle G1/S phase transition  (IMP)
negative regulation of cell population proliferation  (IBA,IEA,ISO)
negative regulation of cell-substrate adhesion  (IMP)
negative regulation of DNA-templated transcription  (ISO)
negative regulation of epithelial cell proliferation  (IMP)
negative regulation of fibroblast proliferation  (ISO)
negative regulation of JNK cascade  (IEA,ISO)
negative regulation of organ growth  (ISO)
negative regulation of osteoblast differentiation  (IEA,ISO)
negative regulation of protein phosphorylation  (IEA,ISO)
negative regulation of stem cell proliferation  (ISO)
negative regulation of transcription by RNA polymerase II  (IEA,IMP,ISO)
negative regulation of type B pancreatic cell proliferation  (ISO)
organ growth  (ISO)
ossification  (ISO)
osteoblast development  (IEA,ISO)
osteoblast fate commitment  (ISO)
positive regulation of cell division  (ISO)
positive regulation of DNA-templated transcription  (ISO)
positive regulation of fibroblast apoptotic process  (ISO)
positive regulation of gene expression  (ISO)
positive regulation of osteoblast differentiation  (ISO)
positive regulation of stem cell differentiation  (ISO)
positive regulation of transcription by RNA polymerase II  (IEA,IMP,ISO)
positive regulation of transforming growth factor beta receptor signaling pathway  (IEA,ISO)
regulation of activin receptor signaling pathway  (IMP)
regulation of G1/S transition of mitotic cell cycle  (ISO)
regulation of gene expression  (ISO)
regulation of transcription by RNA polymerase II  (IBA)
regulation of type B pancreatic cell proliferation  (IMP)
response to gamma radiation  (IEA,ISO)
response to transforming growth factor beta  (IMP)
response to UV  (IEA,ISO)
roof of mouth development  (ISO)
stem cell differentiation  (ISO)
stem cell proliferation  (ISO)
T-helper 2 cell differentiation  (IEA,ISO)
transcription initiation-coupled chromatin remodeling  (IEA,ISO)
type B pancreatic cell differentiation  (IMP)
type B pancreatic cell proliferation  (ISO)

Cellular Component

Molecular Pathway Annotations     Click to see Annotation Detail View
Phenotype Annotations     Click to see Annotation Detail View

Mammalian Phenotype
References

References - curated
# Reference Title Reference Citation
1. Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions. Anlauf M, etal., Gut. 2007 May;56(5):637-44. Epub 2006 Nov 29.
2. Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system. Arnold CN, etal., Int J Cancer. 2007 May 15;120(10):2157-64.
3. Differential and complementary effects of glucose and prolactin on islet DNA synthesis and gene expression. Arumugam R, etal., Endocrinology. 2011 Mar;152(3):856-68. doi: 10.1210/en.2010-1258. Epub 2011 Jan 14.
4. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1. Balogh K, etal., Clin Endocrinol (Oxf). 2007 Nov;67(5):727-34.
5. Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Bertolino P, etal., Cancer Res. 2003 Aug 15;63(16):4836-41.
6. Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma. Cavallari I, etal., Genes Chromosomes Cancer. 2009 May;48(5):383-96.
7. Of mice and MEN1: Insulinomas in a conditional mouse knockout. Crabtree JS, etal., Mol Cell Biol. 2003 Sep;23(17):6075-85.
8. Recessive transmission of a multiple endocrine neoplasia syndrome in the rat. Fritz A, etal., Cancer Res 2002 Jun 1;62(11):3048-51.
9. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
10. Rat ISS GO annotations from GOA human gene data--August 2006 GOA data from the GO Consortium
11. Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma. Hamze Z, etal., Endocr Relat Cancer. 2013 Oct 24;20(6):833-48. doi: 10.1530/ERC-13-0164. Print 2013 Dec.
12. Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia. Harding B, etal., Endocr Relat Cancer. 2009 Dec;16(4):1313-27. Epub 2009 Jul 20.
13. Characteristics of the Danish families with multiple endocrine neoplasia type 1. Jager AC, etal., Mol Cell Endocrinol. 2006 Apr 25;249(1-2):123-32. Epub 2006 Mar 23.
14. MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1. Jiang XH, etal., Endocr Relat Cancer. 2007 Dec;14(4):1073-9.
15. Cell cycle regulation of menin expression. Kaji H, etal., Cancer Res. 1999 Oct 15;59(20):5097-101.
16. Primary structure, gene expression and chromosomal mapping of rodent homologs of the MEN1 tumor suppressor gene. Karges W, etal., Biochim Biophys Acta 1999 Sep 3;1446(3):286-94.
17. Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Karnik SK, etal., Science. 2007 Nov 2;318(5851):806-9.
18. Multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas in Japan. Kawamura J, etal., Oncol Rep. 2005 Jul;14(1):47-52.
19. Activin inhibits pituitary prolactin expression and cell growth through Smads, Pit-1 and menin. Lacerte A, etal., Mol Endocrinol. 2004 Jun;18(6):1558-69. Epub 2004 Mar 18.
20. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Lemmens I, etal., Hum Mol Genet. 1997 Jul;6(7):1177-83.
21. alpha Cell-Specific Men1 Ablation Triggers the Transdifferentiation of Glucagon-Expressing Cells and Insulinoma Development. Lu J, etal., Gastroenterology. 2010 Feb 2.
22. Reexpression of oncoprotein MafB in proliferative beta-cells and Men1 insulinomas in mouse. Lu J, etal., Oncogene. 2012 Aug 2;31(31):3647-54. doi: 10.1038/onc.2011.538. Epub 2011 Nov 28.
23. Structure and distribution of rat menin mRNA. Maruyama K, etal., Mol Cell Endocrinol 1999 Oct 25;156(1-2):25-33.
24. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
25. Electronic Transfer of LocusLink and RefSeq Data NCBI rat LocusLink and RefSeq merged data July 26, 2002
26. Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23. Ohkura N, etal., Biochem Biophys Res Commun. 2001 Apr 20;282(5):1206-10.
27. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
28. Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1. Owens M, etal., Clin Endocrinol (Oxf). 2008 Mar;68(3):350-4. Epub 2007 Sep 14.
29. Two novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1. Ozturk M, etal., J Endocrinol Invest. 2006 Jun;29(6):523-7.
30. Novel germline mutations of the MEN1 gene in Greek families with multiple endocrine neoplasia type 1. Peppa M, etal., Clin Endocrinol (Oxf). 2009 Jan;70(1):75-81. Epub 2008 Jun 12.
31. Reduction of menin expression enhances cell proliferation and is tumorigenic in intestinal epithelial cells. Ratineau C, etal., J Biol Chem 2004 Jun 4;279(23):24477-84. Epub 2004 Mar 30.
32. GOA pipeline RGD automated data pipeline
33. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
34. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
35. Comprehensive gene review and curation RGD comprehensive gene curation
36. Multiple endocrine neoplasia type 1: new clinical and basic findings. Schussheim DH, etal., Trends Endocrinol Metab. 2001 May-Jun;12(4):173-8.
37. Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1. Shen HC, etal., Cancer Res. 2009 Mar 1;69(5):1858-66. Epub 2009 Feb 10.
38. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Shilatifard A Annu Rev Biochem. 2012;81:65-95. doi: 10.1146/annurev-biochem-051710-134100.
39. Tentative Sequence Identification Numbers Tentative Sequence Data IDs. TIGR Gene Index, Rat Data
40. Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases. Tham E, etal., J Clin Endocrinol Metab. 2007 Sep;92(9):3389-95. Epub 2007 Jul 10.
41. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients. Trouillas J, etal., Am J Surg Pathol. 2008 Apr;32(4):534-43.
42. Microsatellite instability and loss of heterozygosity at the MEN1 locus in lung carcinoid tumors: a novel approach using real-time PCR with melting curve analysis in histopathologic material. Vageli D, etal., Oncol Rep. 2006 Mar;15(3):557-64.
43. Changes in global gene expression during in vitro decidualization of rat endometrial stromal cells. Vallejo G, etal., J Cell Physiol. 2010 Jan;222(1):127-37. doi: 10.1002/jcp.21929.
44. Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation. Vierimaa O, etal., Eur J Endocrinol. 2007 Sep;157(3):285-94.
45. Increased menin expression in sporadic pituitary adenomas. Wrocklage C, etal., Clin Endocrinol (Oxf). 2002 May;56(5):589-94.
46. Glucose-mediated repression of menin promotes pancreatic beta-cell proliferation. Zhang H, etal., Endocrinology. 2012 Feb;153(2):602-11. doi: 10.1210/en.2011-1460. Epub 2011 Dec 13.
47. Early changes of beta-Catenins and Menins in spinal cord dorsal horn after peripheral nerve injury. Zhang X, etal., Cell Mol Neurobiol. 2010 Aug;30(6):885-90. doi: 10.1007/s10571-010-9517-9. Epub 2010 Apr 6.
Additional References at PubMed
PMID:8889548   PMID:9465067   PMID:9824159   PMID:9989505   PMID:11158604   PMID:11274402   PMID:11500056   PMID:11526476   PMID:12203793   PMID:12226747   PMID:12477932   PMID:12837246  
PMID:12874027   PMID:14508515   PMID:14633735   PMID:14688275   PMID:14992727   PMID:15044367   PMID:15060136   PMID:15150273   PMID:15199122   PMID:15331604   PMID:15563473   PMID:15640349  
PMID:16195383   PMID:16415155   PMID:16690369   PMID:16740708   PMID:17044021   PMID:17409423   PMID:17500065   PMID:17927973   PMID:18590796   PMID:20484083   PMID:20956546   PMID:23784080  
PMID:24531709   PMID:24824656   PMID:25317587   PMID:30792230   PMID:31652443  


Genomics

Comparative Map Data
Men1
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81213,068,166 - 213,074,132 (+)NCBIGRCr8
mRatBN7.21203,638,905 - 203,644,871 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1203,639,000 - 203,644,871 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1211,987,807 - 211,993,657 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01219,084,356 - 219,090,206 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01211,775,412 - 211,781,262 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01221,704,394 - 221,710,343 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1221,704,493 - 221,710,331 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01228,692,520 - 228,698,433 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41209,114,987 - 209,120,837 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11209,273,349 - 209,279,258 (+)NCBI
Celera1201,172,444 - 201,178,294 (+)NCBICelera
Cytogenetic Map1q43NCBI
MEN1
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381164,803,516 - 64,811,294 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1164,803,510 - 64,811,294 (-)EnsemblGRCh38hg38GRCh38
GRCh371164,570,988 - 64,578,766 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 361164,327,564 - 64,335,342 (-)NCBINCBI36Build 36hg18NCBI36
Build 341164,327,571 - 64,335,342NCBI
Celera1161,897,163 - 61,904,940 (-)NCBICelera
Cytogenetic Map11q13.1NCBI
HuRef1160,898,267 - 60,932,150 (-)NCBIHuRef
CHM1_11164,454,762 - 64,462,538 (-)NCBICHM1_1
T2T-CHM13v2.01164,796,826 - 64,804,601 (-)NCBIT2T-CHM13v2.0
Men1
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39196,385,009 - 6,390,924 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl196,385,009 - 6,390,921 (+)EnsemblGRCm39 Ensembl
GRCm38196,334,979 - 6,340,894 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl196,334,979 - 6,340,891 (+)EnsemblGRCm38mm10GRCm38
MGSCv37196,334,979 - 6,340,894 (+)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv36196,335,039 - 6,340,889 (+)NCBIMGSCv36mm8
Celera196,207,959 - 6,213,874 (+)NCBICelera
Cytogenetic Map19ANCBI
cM Map194.45NCBI
Men1
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_00495542220,356,491 - 20,363,575 (+)EnsemblChiLan1.0
ChiLan1.0NW_00495542220,356,491 - 20,363,374 (+)NCBIChiLan1.0ChiLan1.0
MEN1
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v2966,029,580 - 66,036,592 (-)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan11167,072,415 - 67,079,573 (-)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v01160,159,009 - 60,166,222 (-)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.11163,499,954 - 63,507,164 (-)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl1163,499,962 - 63,507,164 (-)Ensemblpanpan1.1panPan2
MEN1
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.11852,346,747 - 52,352,884 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl1852,346,933 - 52,353,340 (+)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha1850,954,682 - 50,959,679 (+)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.01853,387,971 - 53,394,108 (+)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl1853,388,138 - 53,394,414 (+)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.11852,483,508 - 52,488,505 (+)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.01852,069,239 - 52,074,237 (+)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.01852,853,531 - 52,858,531 (+)NCBIUU_Cfam_GSD_1.0
Men1
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_0244049478,062,038 - 8,068,200 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_0049365994,504,397 - 4,510,555 (+)EnsemblSpeTri2.0SpeTri2.0 Ensembl
SpeTri2.0NW_0049365994,504,489 - 4,510,085 (+)NCBISpeTri2.0SpeTri2.0SpeTri2.0
MEN1
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl27,358,218 - 7,364,952 (+)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.127,358,130 - 7,364,952 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.226,490,697 - 6,497,526 (+)NCBISscrofa10.2Sscrofa10.2susScr3
MEN1
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.119,423,885 - 9,431,123 (+)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl19,423,917 - 9,431,104 (+)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_023666038106,810,667 - 106,817,860 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Men1
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_00462476721,579,103 - 21,585,373 (+)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_00462476721,579,084 - 21,585,380 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2

Variants

.
Variants in Men1
12 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:579
Count of miRNA genes:201
Interacting mature miRNAs:247
Transcripts:ENSRNOT00000028592, ENSRNOT00000037583
Prediction methods:Microtar, Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
61341Bp26Blood pressure QTL 26arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1169537671214537671Rat
61376Bp42Blood pressure QTL 4223.4arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1197814409242814409Rat
619613Bp77Blood pressure QTL 770.01arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1164747424209747424Rat
619613Bp77Blood pressure QTL 770.01arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)1164747424209747424Rat
631214Bw61Body weight QTL613.40.0001intramuscular adipose amount (VT:0010044)intramuscular fat area (CMO:0001162)1173108781218108781Rat
70163Bw20Body weight QTL 205.1body mass (VT:0001259)body weight (CMO:0000012)1174133260219133260Rat
724531Uae5Urinary albumin excretion QTL 54urine albumin amount (VT:0002871)urine albumin level (CMO:0000130)1150700142252085212Rat
724559Pancm1Pancreatic morphology QTL 17.1islet of Langerhans morphology trait (VT:0005215)pancreatic islet damage composite score (CMO:0001156)1181759564214537555Rat
724562Rends1Renal damage susceptibility QTL 10.05kidney glomerulus integrity trait (VT:0010546)index of glomerular damage (CMO:0001135)1169537671214537671Rat
737828Hcas3Hepatocarcinoma susceptibility QTL 34.9liver integrity trait (VT:0010547)liver tumorous lesion volume to total liver volume ratio (CMO:0001082)1144267353222987745Rat
1298084Thym4Thymus enlargement QTL 410.68thymus mass (VT:0004954)thymus weight to body weight ratio (CMO:0000612)1197814409242814409Rat
631658Cm7Cardiac mass QTL 75.320.0001aorta mass (VT:0002845)aorta weight (CMO:0000076)1196248093241248093Rat
737977Bp160Blood pressure QTL 1600.001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1181133855226133855Rat
731168Bp154Blood pressure QTL 1543.4arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)194642644214537671Rat
738032Hcas5Hepatocarcinoma susceptibility QTL 53.12liver integrity trait (VT:0010547)liver tumorous lesion number (CMO:0001068)1176426412257976495Rat
631838Niddm36Non-insulin dependent diabetes mellitus QTL 360.01insulin secretion trait (VT:0003564)calculated pancreatic islet insulin release measurement (CMO:0001217)1184550676229550676Rat
634312Bp143Blood pressure QTL 14330.0002arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1182623426219932796Rat
634313Niddm43Non-insulin dependent diabetes mellitus QTL 43blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)1199050459259647894Rat
634321Hc1Hypercalciuria QTL 12.91urine calcium amount (VT:0002985)urine calcium excretion rate (CMO:0000763)1178810256240830002Rat
634338Hcar4Hepatocarcinoma resistance QTL 44.6liver integrity trait (VT:0010547)liver tumorous lesion number to liver area ratio (CMO:0001210)1193422268214537671Rat
1300145Rf7Renal function QTL 72.96urine creatinine amount (VT:0010540)urine creatinine level (CMO:0000125)1185145134221264292Rat
1331790Bp201Blood pressure QTL 2013.127arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1198211513225126682Rat
1354580Scort1Serum corticosterone level QTL 13.4blood corticosterone amount (VT:0005345)blood corticosterone level (CMO:0001172)1156677124256448636Rat
1302787Stl25Serum triglyceride level QTL 252.70.0073blood triglyceride amount (VT:0002644)plasma triglyceride level (CMO:0000548)1180359209210702199Rat
1357335Bw39Body weight QTL 393.3body mass (VT:0001259)body weight (CMO:0000012)1197814409242814409Rat
1354606Bp246Blood pressure QTL 2463.6arterial blood pressure trait (VT:2000000)pulse pressure (CMO:0000292)1102813953218753816Rat
1354610Bw34Body weight QTL 344.1body mass (VT:0001259)body weight (CMO:0000012)1151162512256448636Rat
1354624Cm35Cardiac mass QTL355.7heart left ventricle mass (VT:0007031)calculated heart weight (CMO:0000073)1177227632256448636Rat
1354646Kidm18Kidney mass QTL 185.7kidney mass (VT:0002707)calculated kidney weight (CMO:0000160)1151162512256448636Rat
1354652Kidm20Kidney mass QTL 204.3kidney mass (VT:0002707)calculated kidney weight (CMO:0000160)1177227632256448636Rat
1354653Despr9Despair related QTL 90.00019locomotor behavior trait (VT:0001392)amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958)1167909849212909849Rat
1354661Bw33Body weight QTL 335.2body mass (VT:0001259)body weight (CMO:0000012)1151162512256448636Rat
1558658Bw59Body weight QTL 593.50.0003body mass (VT:0001259)body weight (CMO:0000012)1178784622223784622Rat
1549837Hcar15Hepatocarcinoma resistance QTL 150.05liver integrity trait (VT:0010547)liver tumorous lesion number (CMO:0001068)1153136852260522016Rat
1358191Ept10Estrogen-induced pituitary tumorigenesis QTL 103.8pituitary gland mass (VT:0010496)pituitary gland wet weight (CMO:0000853)1192825253243914732Rat
1358886Bp260Blood pressure QTL 2603.67arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1151162766225824951Rat
1358898Bp255Blood pressure QTL 2553.6arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1191019702246062233Rat
1549830Bss1Bone structure and strength QTL 14.8femur strength trait (VT:0010010)femur ultimate force (CMO:0001675)1172609619217609619Rat
1358292Cm37Cardiac mass QTL 376.20.00000081heart mass (VT:0007028)heart weight to body weight ratio (CMO:0000074)1196248093241248093Rat
1358294Bw37Body weight QTL 3750.000011body mass (VT:0001259)body weight (CMO:0000012)1171310381216310381Rat
1582206Kidm33Kidney mass QTL 336.9kidney mass (VT:0002707)both kidneys wet weight to body weight ratio (CMO:0000340)1188377360224054420Rat
1641926Teswt2Testicular weight QTL 22.82testis mass (VT:1000644)both testes wet weight (CMO:0000175)1197697768238755659Rat
1598853Memor3Memory QTL 34.5exploratory behavior trait (VT:0010471)total horizontal distance resulting from voluntary locomotion in an experimental apparatus (CMO:0001443)1143506580212458660Rat
1600374Mcs17Mammary carcinoma susceptibility QTL 173mammary gland integrity trait (VT:0010552)mammary tumor number (CMO:0000343)1197670404242670404Rat
1600380Niddm70Non-insulin dependent diabetes mellitus QTL 703.10.0008blood insulin amount (VT:0001560)plasma insulin level (CMO:0000342)1176550523221550523Rat
1600388Niddm67Non-insulin dependent diabetes mellitus QTL 675.840.000004blood glucose amount (VT:0000188)blood glucose level area under curve (AUC) (CMO:0000350)1195804352257091168Rat
1600395Niddm69Non-insulin dependent diabetes mellitus QTL 694.140.0002blood insulin amount (VT:0001560)plasma insulin level (CMO:0000342)1195804352257091168Rat
1600396Niddm68Non-insulin dependent diabetes mellitus QTL 684.970.0003blood glucose amount (VT:0000188)blood glucose level area under curve (AUC) (CMO:0000350)1195804352257091168Rat
1578759Uae30Urinary albumin excretion QTL 303.30.003urine albumin amount (VT:0002871)urine albumin excretion rate (CMO:0000757)1150700247252085048Rat
1578763Kidm29Kidney mass QTL 293.30.0001kidney mass (VT:0002707)both kidneys wet weight (CMO:0000085)1179567751260522016Rat
1578778Pur4Proteinuria QTL 43.30.003urine total protein amount (VT:0000032)urine total protein excretion rate (CMO:0000756)1150700247252085048Rat
1578780Cm52Cardiac mass QTL 523.30.0001heart mass (VT:0007028)heart wet weight (CMO:0000069)181591954219808434Rat
2292220Bp306Blood pressure QTL 3063.470.00087arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1164310393243914901Rat
2292222Bp307Blood pressure QTL 3073.060.0014arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1164310393213533942Rat
2293083Iddm25Insulin dependent diabetes mellitus QTL 254.18blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)1181829673224569684Rat
2292218Kidm35Kidney mass QTL 35kidney mass (VT:0002707)both kidneys wet weight to body weight ratio (CMO:0000340)1199368955224569684Rat
2302375Bw83Body weight QTL 834.870.0002body mass (VT:0001259)body weight (CMO:0000012)1197697768242697768Rat
2302378Insul11Insulin level QTL 113.25blood insulin amount (VT:0001560)serum insulin level (CMO:0000358)1144267353251128347Rat
2300161Bmd43Bone mineral density QTL 438.40.0001femur mineral mass (VT:0010011)volumetric bone mineral density (CMO:0001553)1171629477216629477Rat
2300174Bmd42Bone mineral density QTL 428.40.0001lumbar vertebra mineral mass (VT:0010511)bone mineral density (CMO:0001226)1171629477216629477Rat
2300175Bmd40Bone mineral density QTL 4015.40.0001femur mineral mass (VT:0010011)bone mineral density (CMO:0001226)1201554356246554356Rat
2300187Bmd41Bone mineral density QTL 418.90.0001femur mineral mass (VT:0010011)volumetric bone mineral density (CMO:0001553)1171629477216629477Rat
2293654Bss30Bone structure and strength QTL 3032.650.0001femur strength trait (VT:0010010)femur midshaft polar moment of inertia (CMO:0001669)1171629477216629477Rat
2293655Bss36Bone structure and strength QTL 3610.660.0001femur strength trait (VT:0010010)femur ultimate force (CMO:0001675)1201554356246554356Rat
2293673Bss27Bone structure and strength QTL 2718.630.0001femur morphology trait (VT:0000559)femur midshaft cortical cross-sectional area (CMO:0001663)1171629477216629477Rat
2293674Bss39Bone structure and strength QTL 397.10.0001femur strength trait (VT:0010010)femur total energy absorbed before break (CMO:0001677)1201554356246554356Rat
2293677Bss41Bone structure and strength QTL 419.380.0001lumbar vertebra size trait (VT:0010518)lumbar vertebra cross-sectional area (CMO:0001689)1171629477216629477Rat
2293689Bss47Bone structure and strength QTL 477.250.0001lumbar vertebra size trait (VT:0010518)lumbar vertebra trabecular cross-sectional area (CMO:0001692)1171629477216629477Rat
2293693Bss22Bone structure and strength QTL 2233.520.0001femur morphology trait (VT:0000559)femur cross-sectional area (CMO:0001661)1171629477216629477Rat
2293694Bss38Bone structure and strength QTL 387.050.0001femur strength trait (VT:0010010)femur stiffness (CMO:0001674)1201554356246554356Rat
2312420Pur17Proteinuria QTL 177.10.0001urine protein amount (VT:0005160)urine total protein excretion rate (CMO:0000756)1156677124218753816Rat
2312564Glom18Glomerulus QTL 182.40.003kidney glomerulus morphology trait (VT:0005325)index of glomerular damage (CMO:0001135)1185356336231689108Rat
6903303Scl34Serum cholesterol QTL 342.50.0033blood cholesterol amount (VT:0000180)plasma total cholesterol level (CMO:0000585)1180359209218108781Rat
8655655Arrd2Age-related retinal degeneration QTL 27.79retinal layer morphology trait (VT:0003727)percentage of study population developing retinopathy during a period of time (CMO:0002453)1183970203243914901Rat
7794788Mcs32Mammary carcinoma susceptibility QTL 322.61mammary gland integrity trait (VT:0010552)mammary tumor incidence/prevalence measurement (CMO:0000946)1115540693238914717Rat
7771612Cm80Cardiac mass QTL 808.4heart left ventricle mass (VT:0007031)heart left ventricle weight (CMO:0000776)1149448574221264292Rat
7421630Bp362Blood pressure QTL 3620.001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1118608292241799120Rat
8552891Epfw5Epididymal fat weight QTL 54.4epididymal fat pad mass (VT:0010421)epididymal fat pad weight to body weight ratio (CMO:0000658)1193113876238113876Rat
7394701Uae46Urinary albumin excretion QTL 463.60.0056urine albumin amount (VT:0002871)urine albumin excretion rate (CMO:0000757)1201554356246554356Rat
8655855Arrd3Age-related retinal degeneration QTL 33.07lens clarity trait (VT:0001304)cataract incidence/prevalence measurement (CMO:0001585)1183970203243914901Rat
10059587Bw173Body weight QTL 1733.230.025body mass (VT:0001259)body weight (CMO:0000012)1202069611247069611Rat
10059590Kidm44Kidney mass QTL 443.420.025kidney mass (VT:0002707)both kidneys wet weight to body weight ratio (CMO:0000340)1191033875236033875Rat
10059600Bp378Blood pressure QTL 3783.080.05arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1176869060221869060Rat


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system appendage
High
Medium 3 28 49 33 18 33 74 30 36 11
Low 15 8 8 1 8 8 11 5 5 8
Below cutoff

Sequence

Nucleotide Sequences
RefSeq Transcripts NM_019208 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_006230769 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_006230770 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_006230771 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_006230772 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_039109376 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_063287501 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
GenBank Nucleotide AB023400 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AF130369 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AF130370 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BQ193347 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CB773186 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CB814296 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CH473953 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CV079282 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  JAXUCZ010000001 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  KF027404 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles

RefSeq Acc Id: ENSRNOT00000028592   ⟹   ENSRNOP00000028592
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1203,639,000 - 203,644,871 (+)Ensembl
Rnor_6.0 Ensembl1221,704,493 - 221,710,331 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000099846   ⟹   ENSRNOP00000076697
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1203,639,007 - 203,644,116 (+)Ensembl
RefSeq Acc Id: NM_019208   ⟹   NP_062081
RefSeq Status: VALIDATED
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81213,068,282 - 213,074,132 (+)NCBI
mRatBN7.21203,639,021 - 203,644,871 (+)NCBI
Rnor_6.01221,704,493 - 221,710,343 (+)NCBI
Rnor_5.01228,692,520 - 228,698,433 (+)NCBI
RGSC_v3.41209,114,987 - 209,120,837 (+)RGD
Celera1201,172,444 - 201,178,294 (+)RGD
Sequence:
RefSeq Acc Id: XM_006230769   ⟹   XP_006230831
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81213,068,166 - 213,073,849 (+)NCBI
mRatBN7.21203,638,905 - 203,644,871 (+)NCBI
Rnor_6.01221,704,425 - 221,710,343 (+)NCBI
Rnor_5.01228,692,520 - 228,698,433 (+)NCBI
Sequence:
RefSeq Acc Id: XM_006230770   ⟹   XP_006230832
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81213,068,254 - 213,073,849 (+)NCBI
mRatBN7.21203,638,987 - 203,644,871 (+)NCBI
Rnor_6.01221,704,488 - 221,710,343 (+)NCBI
Rnor_5.01228,692,520 - 228,698,433 (+)NCBI
Sequence:
RefSeq Acc Id: XM_006230771   ⟹   XP_006230833
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81213,068,176 - 213,073,849 (+)NCBI
mRatBN7.21203,638,910 - 203,644,871 (+)NCBI
Rnor_6.01221,704,431 - 221,710,343 (+)NCBI
Rnor_5.01228,692,520 - 228,698,433 (+)NCBI
Sequence:
RefSeq Acc Id: XM_006230772   ⟹   XP_006230834
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81213,068,224 - 213,073,849 (+)NCBI
mRatBN7.21203,638,958 - 203,644,871 (+)NCBI
Rnor_6.01221,704,394 - 221,710,343 (+)NCBI
Rnor_5.01228,692,520 - 228,698,433 (+)NCBI
Sequence:
RefSeq Acc Id: XM_039109376   ⟹   XP_038965304
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81213,068,166 - 213,073,849 (+)NCBI
mRatBN7.21203,638,905 - 203,643,799 (+)NCBI
RefSeq Acc Id: XM_063287501   ⟹   XP_063143571
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81213,068,262 - 213,073,849 (+)NCBI
RefSeq Acc Id: NP_062081   ⟸   NM_019208
- UniProtKB: D3ZCA2 (UniProtKB/Swiss-Prot),   Q9WVR8 (UniProtKB/Swiss-Prot),   A0A8L2QI00 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: XP_006230831   ⟸   XM_006230769
- Peptide Label: isoform X1
- UniProtKB: A6HZG1 (UniProtKB/TrEMBL),   A0A8L2QI00 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: XP_006230833   ⟸   XM_006230771
- Peptide Label: isoform X2
- UniProtKB: D3ZCA2 (UniProtKB/Swiss-Prot),   Q9WVR8 (UniProtKB/Swiss-Prot),   A0A8L2QI00 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: XP_006230834   ⟸   XM_006230772
- Peptide Label: isoform X2
- UniProtKB: D3ZCA2 (UniProtKB/Swiss-Prot),   Q9WVR8 (UniProtKB/Swiss-Prot),   A0A8L2QI00 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: XP_006230832   ⟸   XM_006230770
- Peptide Label: isoform X2
- UniProtKB: D3ZCA2 (UniProtKB/Swiss-Prot),   Q9WVR8 (UniProtKB/Swiss-Prot),   A0A8L2QI00 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSRNOP00000028592   ⟸   ENSRNOT00000028592
RefSeq Acc Id: XP_038965304   ⟸   XM_039109376
- Peptide Label: isoform X3
RefSeq Acc Id: ENSRNOP00000076697   ⟸   ENSRNOT00000099846
RefSeq Acc Id: XP_063143571   ⟸   XM_063287501
- Peptide Label: isoform X4

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-Q9WVR8-F1-model_v2 AlphaFold Q9WVR8 1-610 view protein structure

Transcriptome

eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

Promoters
RGD ID:13690697
Promoter ID:EPDNEW_R1220
Type:initiation region
Name:Men1_1
Description:menin 1
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Rat AssemblyChrPosition (strand)Source
Rnor_6.01221,704,479 - 221,704,539EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:3078 AgrOrtholog
BioCyc Gene G2FUF-56599 BioCyc
Ensembl Genes ENSRNOG00000021054 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  ENSRNOG00055022337 UniProtKB/Swiss-Prot
  ENSRNOG00060032676 UniProtKB/Swiss-Prot
  ENSRNOG00065029138 UniProtKB/Swiss-Prot
Ensembl Transcript ENSRNOT00000028592.7 UniProtKB/TrEMBL
  ENSRNOT00000099846.1 UniProtKB/Swiss-Prot
  ENSRNOT00055038395 UniProtKB/Swiss-Prot
  ENSRNOT00060056649 UniProtKB/Swiss-Prot
  ENSRNOT00065050381 UniProtKB/Swiss-Prot
IMAGE_CLONE IMAGE:7460088 IMAGE-MGC_LOAD
InterPro Menin UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report rno:29417 UniProtKB/Swiss-Prot
MGC_CLONE MGC:114329 IMAGE-MGC_LOAD
NCBI Gene 29417 ENTREZGENE
PANTHER MENIN UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  PTHR12693 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam Menin UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PhenoGen Men1 PhenoGen
RatGTEx ENSRNOG00000021054 RatGTEx
  ENSRNOG00055022337 RatGTEx
  ENSRNOG00060032676 RatGTEx
  ENSRNOG00065029138 RatGTEx
TIGR TC217567
UniProt A0A8L2QI00 ENTREZGENE, UniProtKB/TrEMBL
  A6HZG1 ENTREZGENE, UniProtKB/TrEMBL
  D3ZCA2 ENTREZGENE
  MEN1_RAT UniProtKB/Swiss-Prot, ENTREZGENE
UniProt Secondary D3ZCA2 UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2015-12-02 Men1  menin 1  Men1  multiple endocrine neoplasia I  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2012-02-22 Men1  multiple endocrine neoplasia I  Men1  multiple endocrine neoplasia 1  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2002-06-10 Men1  multiple endocrine neoplasia 1      Name updated 70584 APPROVED

RGD Curation Notes
Note Type Note Reference
gene_expression expressed in the developing brain and in the endocrine, digestive, reproductive, and immune systems 69890